Home
United States Code
U.S.C. Title 42-THE PUBLIC HEALTH AND WELFARE
CHAPTER 6A-PUBLIC HEALTH SERVICE
SUBCHAPTER III-NATIONAL RESEARCH INSTITUTES
Part B-General Provisions Respecting National Research Institutes

42 U.S. Code § 284j

PREV NEXT

Muscular dystrophy research

Ok Cancel

Don't show this message again

42 U.S. Code § 284j. Muscular dystrophy research

(a) Coordination of activities

The Director of NIH shall expand and increase coordination in the activities of the National Institutes of Health with respect to research on muscular dystrophies, including Duchenne muscular dystrophy.

This document is only available to subscribers. Please log in or purchase access.

Purchase Login

PREV NEXT

Navigation

Current through

The United States Code on COSMOS is current through Public Law 118-34 (12/26/2023), except for Public Law 118-31.

Part B-General Provisions Respecting National Research Institutes

§284 Directors of national research institutes
§284a Advisory councils
§284b Repealed. Pub. L. 109-482, title I, § 104(b)(1)(C), Jan. 15, 2007, 120 Stat. 3693
§284c Certain uses of funds
§284d Definitions
§284e Research on osteoporosis, Paget’s disease, and related bone disorders
§284f Parkinson’s disease
§284g Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
§284h Pediatric Research Initiative
§284i Autoimmune diseases
§284j Muscular dystrophy research
§284k Clinical research
§284l Enhancement awards
§284m Program for pediatric studies of drugs
§284m-1 Pediatric Advisory Committee
§284n Certain demonstration projects
§284o Activities of the National Institutes of Health with respect to research on paralysis
§284p Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
§284q Pain research
§284q-1 NIH opioid research
§284r Basic research
§284s Tick-borne diseases

U.S. Code Popular Name Table

Popular Names

Americans with Disabilities Act 42 U.S.C. § 12101 et seq.

Anti-Kickback Statute 42 U.S.C. § 1320a–7b(b)

Clayton Act 15 U.S.C. § 12 et seq.

Clean Air Act 42 U.S.C. § 7401 et seq.

Commodity Exchange Act 7 U.S.C. § 1

Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA) 42 U.S.C. § 9601 et seq.

Controlled Substances Act 21 U.S.C. § 801 et seq.

Emergency Medical Treatment and Labor Act (EMTALA) 42 U.S.C. § 1395dd

Fair Credit Reporting Act 15 U.S.C. § 1681

False Claims Act 31 U.S.C. § 3729 et seq.

Federal Food, Drug, and Cosmetic Act 21 U.S.C. § 301 et seq.

Federal Insecticide, Fungicide, and Rodenticide Act 7 U.S.C. § 136 et seq.

Federal Trade Commission Act 15 U.S.C. § 41 et seq.

Foreign corrupt Practices Act 15 U.S.C. § 78dd-1 et seq.

Fraud Enforcement and Recovery Act of 2009 (FERA) 18 U.S.C. § 27

Health Information Technology for Economic and Clinical Health Act (HITECH) 42 U.S.C. § 300jj et seq., 42 U.S.C. § 17901 et seq.

Health Insurance Portability and Accountability Act of 1996 (HIPAA) 42 U.S.C. § 201

National Environmental Policy Act (NEPA) 42 U.S.C. § 4321 et seq.

Patient Protection and Affordable Care Act 42 U.S.C. § 18001 et seq.

Physician Payments Sunshine Act 42 U.S.C. § 1320a–7h

Public Health Service Act 42 U.S.C. § 201 et seq.

Resource Conservation and Recovery Act (RCRA) 42 U.S.C. § 6901 et seq.

Robinson–Patman Act 15 U.S.C. § 13

Sarbanes-Oxley Act 15 U.S.C. § 7201 et seq.

Securities Act of 1933 15 U.S.C. § 77a et seq.

Sentencing Reform Act of 1984 18 U.S.C. § 3551 et seq.

Sherman Act 15 U.S.C. § 1 et seq.

Social Security Act 42 U.S.C. § 301 et seq.

Stark Law 42 U.S.C. § 1395nn

Toxic Substances Control Act 15 U.S.C. § 2601 et seq.

Muscular dystrophy research

42 U.S. Code § 284j. Muscular dystrophy research

Navigation

Table of Contents

952.933.4977

952.988.0141